These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

593 related items for PubMed ID: 17085653

  • 1. Reduced expression of the breast cancer metastasis suppressor 1 mRNA is correlated with poor progress in breast cancer.
    Zhang Z, Yamashita H, Toyama T, Yamamoto Y, Kawasoe T, Iwase H.
    Clin Cancer Res; 2006 Nov 01; 12(21):6410-4. PubMed ID: 17085653
    [Abstract] [Full Text] [Related]

  • 2. ATBF1-a messenger RNA expression is correlated with better prognosis in breast cancer.
    Zhang Z, Yamashita H, Toyama T, Sugiura H, Ando Y, Mita K, Hamaguchi M, Kawaguchi M, Miura Y, Iwase H.
    Clin Cancer Res; 2005 Jan 01; 11(1):193-8. PubMed ID: 15671546
    [Abstract] [Full Text] [Related]

  • 3. Quantitation of HDAC1 mRNA expression in invasive carcinoma of the breast*.
    Zhang Z, Yamashita H, Toyama T, Sugiura H, Ando Y, Mita K, Hamaguchi M, Hara Y, Kobayashi S, Iwase H.
    Breast Cancer Res Treat; 2005 Nov 01; 94(1):11-6. PubMed ID: 16172792
    [Abstract] [Full Text] [Related]

  • 4. HDAC6 expression is correlated with better survival in breast cancer.
    Zhang Z, Yamashita H, Toyama T, Sugiura H, Omoto Y, Ando Y, Mita K, Hamaguchi M, Hayashi S, Iwase H.
    Clin Cancer Res; 2004 Oct 15; 10(20):6962-8. PubMed ID: 15501975
    [Abstract] [Full Text] [Related]

  • 5. NCOR1 mRNA is an independent prognostic factor for breast cancer.
    Zhang Z, Yamashita H, Toyama T, Sugiura H, Ando Y, Mita K, Hamaguchi M, Hara Y, Kobayashi S, Iwase H.
    Cancer Lett; 2006 Jun 08; 237(1):123-9. PubMed ID: 16019133
    [Abstract] [Full Text] [Related]

  • 6. WWOX--the FRA16D cancer gene: expression correlation with breast cancer progression and prognosis.
    Płuciennik E, Kusińska R, Potemski P, Kubiak R, Kordek R, Bednarek AK.
    Eur J Surg Oncol; 2006 Mar 08; 32(2):153-7. PubMed ID: 16360296
    [Abstract] [Full Text] [Related]

  • 7. Altered expression of metastasis-associated and regulatory molecules in effusions from breast cancer patients: a novel model for tumor progression.
    Davidson B, Konstantinovsky S, Nielsen S, Dong HP, Berner A, Vyberg M, Reich R.
    Clin Cancer Res; 2004 Nov 01; 10(21):7335-46. PubMed ID: 15534110
    [Abstract] [Full Text] [Related]

  • 8. Flt-4-positive vessel density correlates with vascular endothelial growth factor-d expression, nodal status, and prognosis in breast cancer.
    Nakamura Y, Yasuoka H, Tsujimoto M, Yang Q, Imabun S, Nakahara M, Nakao K, Nakamura M, Mori I, Kakudo K.
    Clin Cancer Res; 2003 Nov 01; 9(14):5313-7. PubMed ID: 14614015
    [Abstract] [Full Text] [Related]

  • 9. Expression of HER2 and the coamplified genes GRB7 and MLN64 in human breast cancer: quantitative real-time reverse transcription-PCR as a diagnostic alternative to immunohistochemistry and fluorescence in situ hybridization.
    Vinatzer U, Dampier B, Streubel B, Pacher M, Seewald MJ, Stratowa C, Kaserer K, Schreiber M.
    Clin Cancer Res; 2005 Dec 01; 11(23):8348-57. PubMed ID: 16322295
    [Abstract] [Full Text] [Related]

  • 10. Nitric oxide in breast cancer: induction of vascular endothelial growth factor-C and correlation with metastasis and poor prognosis.
    Nakamura Y, Yasuoka H, Tsujimoto M, Yoshidome K, Nakahara M, Nakao K, Nakamura M, Kakudo K.
    Clin Cancer Res; 2006 Feb 15; 12(4):1201-7. PubMed ID: 16489074
    [Abstract] [Full Text] [Related]

  • 11. Tumor gene expression and prognosis in breast cancer patients with 10 or more positive lymph nodes.
    Cobleigh MA, Tabesh B, Bitterman P, Baker J, Cronin M, Liu ML, Borchik R, Mosquera JM, Walker MG, Shak S.
    Clin Cancer Res; 2005 Dec 15; 11(24 Pt 1):8623-31. PubMed ID: 16361546
    [Abstract] [Full Text] [Related]

  • 12. Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy.
    Esteva FJ, Sahin AA, Cristofanilli M, Coombes K, Lee SJ, Baker J, Cronin M, Walker M, Watson D, Shak S, Hortobagyi GN.
    Clin Cancer Res; 2005 May 01; 11(9):3315-9. PubMed ID: 15867229
    [Abstract] [Full Text] [Related]

  • 13. [Expression of nm23 in breast cancer: correlation with distant metastasis and prognosis].
    Liu H, Mao H, Fu X.
    Zhonghua Zhong Liu Za Zhi; 2001 May 01; 23(3):224-7. PubMed ID: 11783092
    [Abstract] [Full Text] [Related]

  • 14. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
    D'Andrea MR, Limiti MR, Bari M, Zambenedetti P, Montagutti A, Ricci F, Pappagallo GL, Sartori D, Vinante O, Mingazzini PL.
    Breast Cancer Res Treat; 2007 Mar 01; 101(3):279-84. PubMed ID: 16835704
    [Abstract] [Full Text] [Related]

  • 15. Expression analysis of estrogen receptor alpha coregulators in breast carcinoma: evidence that NCOR1 expression is predictive of the response to tamoxifen.
    Girault I, Lerebours F, Amarir S, Tozlu S, Tubiana-Hulin M, Lidereau R, Bièche I.
    Clin Cancer Res; 2003 Apr 01; 9(4):1259-66. PubMed ID: 12684393
    [Abstract] [Full Text] [Related]

  • 16. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
    Pentheroudakis G, Kalogeras KT, Wirtz RM, Grimani I, Zografos G, Gogas H, Stropp U, Pectasides D, Skarlos D, Hennig G, Samantas E, Bafaloukos D, Papakostas P, Kalofonos HP, Pavlidis N, Fountzilas G.
    Breast Cancer Res Treat; 2009 Jul 01; 116(1):131-43. PubMed ID: 18668363
    [Abstract] [Full Text] [Related]

  • 17. Increased expression of urokinase-type plasminogen activator mRNA determines adverse prognosis in ErbB2-positive primary breast cancer.
    Urban P, Vuaroqueaux V, Labuhn M, Delorenzi M, Wirapati P, Wight E, Senn HJ, Benz C, Eppenberger U, Eppenberger-Castori S.
    J Clin Oncol; 2006 Sep 10; 24(26):4245-53. PubMed ID: 16963728
    [Abstract] [Full Text] [Related]

  • 18. Quantitation of hTERT gene expression in sporadic breast tumors with a real-time reverse transcription-polymerase chain reaction assay.
    Bièche I, Noguès C, Paradis V, Olivi M, Bedossa P, Lidereau R, Vidaud M.
    Clin Cancer Res; 2000 Feb 10; 6(2):452-9. PubMed ID: 10690523
    [Abstract] [Full Text] [Related]

  • 19. High syndecan-1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis.
    Barbareschi M, Maisonneuve P, Aldovini D, Cangi MG, Pecciarini L, Angelo Mauri F, Veronese S, Caffo O, Lucenti A, Palma PD, Galligioni E, Doglioni C.
    Cancer; 2003 Aug 01; 98(3):474-83. PubMed ID: 12879463
    [Abstract] [Full Text] [Related]

  • 20. Expression of transferrin receptor and ferritin H-chain mRNA are associated with clinical and histopathological prognostic indicators in breast cancer.
    Yang DC, Wang F, Elliott RL, Head JF.
    Anticancer Res; 2001 Aug 01; 21(1B):541-9. PubMed ID: 11299801
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.